Considerations regarding an updated meta-analysis of the optimal duration of oxaliplatin-based adjuvant chemotherapy in patients with different risk factors for stage II-III colon cancer

被引：0
|
作者：
Pang, Huayang [1 ,2 ]
Yan, Menghua [1 ]
Chen, Lihui [1 ]
Zhao, Zhou [1 ,2 ]
Li, Wei [1 ]
Zhang, Shouru [1 ]
Sun, Hao [1 ]
机构：
[1] Chongqing Univ Canc Hosp, Dept Gastrointestinal Canc Ctr, Chongqing 400030, Peoples R China
[2] Chongqing Univ Canc Hosp, Chongqing Key Lab Translat Res Canc Metastasis & I, Chongqing, Peoples R China
来源：
INTERNATIONAL JOURNAL OF SURGERY | 2024年 / 110卷 / 07期
关键词：
FLUOROPYRIMIDINE; THERAPY;
D O I：
10.1097/JS9.0000000000001350
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：4431 / 4432
页数：2
相关论文
共 50 条
  • [1] Optimal duration of oxaliplatin-based adjuvant chemotherapy in patients with different risk factors for stage II-III colon cancer: a meta-analysis
    Kuang, Ziyu
    Wang, Jiaxi
    Liu, Kexin
    Wu, Jingyuan
    Li, Jie
    INTERNATIONAL JOURNAL OF SURGERY, 2024, 110 (05) : 3030 - 3038
  • [2] Duration of oxaliplatin-based adjuvant chemotherapy in patients with Stage III or high-risk Stage II resected colon cancer
    Moretto, Roberto
    Falcone, Alfredo
    Cremolini, Chiara
    INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (09) : 2652 - 2654
  • [3] Effect of Delay in Adjuvant Oxaliplatin-Based Chemotherapy for Stage III Colon Cancer
    Peixoto, Renata D'Alpino
    Kumar, Aalok
    Speers, Caroline
    Renouf, Daniel
    Kennecke, Hagen F.
    Lim, Howard J.
    Cheung, Winson Y.
    Melosky, Barbara
    Gill, Sharlene
    CLINICAL COLORECTAL CANCER, 2015, 14 (01) : 25 - 30
  • [4] Impact of delay in adjuvant oxaliplatin-based chemotherapy for stage III colon cancer.
    Peixoto, Renata D'Alpino
    Kumar, Aalok
    Speers, Caroline
    Renouf, Daniel John
    Kennecke, Hagen F.
    Lim, Howard John
    Cheung, Winson Y.
    Melosky, Barbara L.
    Gill, Sharlene
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [5] PHARMACOGENETIC PREDICTORS OF SEVERE CHRONIC PERIPHERAL NEUROPATHY IN STAGE II-III COLON CANCER (CC) PATIENTS TREATED WITH OXALIPLATIN-BASED ADJUVANT CHEMOTHERAPY (CT). A GEMCAD STUDY
    Custodio, A.
    Moreno, J.
    Aparicio, J.
    Gallego Plazas, J.
    Fernandez Martos, C.
    Maurel, J.
    Ramos, D.
    Cejas, P.
    Madero, R.
    Feliu, J.
    ANNALS OF ONCOLOGY, 2012, 23 : 181 - 181
  • [6] Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 12 Trials
    Gallois, Claire
    Shi, Qian
    Pederson, Levi D.
    Andre, Thierry
    Iveson, Timothy J.
    Sobrero, Alberto F.
    Alberts, Steven
    de Gramont, Aimery
    Meyerhardt, Jeffrey A.
    George, Thomas
    Schmoll, Hans-Joachim E.
    Souglakos, Ioannis
    Harkin, Andrea
    Labianca, Roberto
    Sinicrope, Frank A.
    Oki, Eiji
    Shields, Anthony F.
    Boukovinas, Ioannis
    Kerr, Rachel
    Lonardi, Sara
    Yothers, Greg
    Yoshino, Takayuki
    Goldberg, Richard M.
    Taieb, Julien
    Papamichael, Demetris
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (19) : 2295 - 2305
  • [7] Prognostic value of methylator phenotype in stage III colon cancer treated with oxaliplatin-based adjuvant chemotherapy
    Gallois, C.
    Taieb, J.
    Le Corre, D.
    Le Malicot, K.
    Tabernero, J.
    Mulot, C.
    Seitz, J-F.
    Aparicio, T.
    Folprecht, G.
    Lepage, C.
    Mini, E.
    Van Laethem, J-L.
    Emile, J. F.
    Laurent-Puig, P.
    ANNALS OF ONCOLOGY, 2017, 28
  • [8] Prognostic Value of Methylator Phenotype in Stage III Colon Cancer Treated with Oxaliplatin-based Adjuvant Chemotherapy
    Gallois, Claire
    Taieb, Julien
    Le Corre, Delphine
    Le Malicot, Karine
    Tabernero, Josep
    Mulot, Claire
    Seitz, Jean-Francois
    Aparicio, Thomas
    Folprecht, Gunnar
    Lepage, Come
    Mini, Enrico
    Van Laethem, Jean-Luc
    Emile, Jean-Francois
    Laurent-Puig, Pierre
    CLINICAL CANCER RESEARCH, 2018, 24 (19) : 4745 - 4753
  • [9] Cancer stem cells profile and clinical outcome in stage III colon cancer patients receiving adjuvant oxaliplatin-based chemotherapy
    Giampieri, Riccardo
    Scartozzi, Mario
    Loretelli, Cristian
    Del Prete, Michela
    Faloppi, Luca
    Bianconi, Maristella
    Bittoni, Alessandro
    Mandolesi, Alessandra
    Bearzi, Italo
    Cascinu, Stefano
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [10] Adjuvant chemotherapy for high-risk stage II and stage III colon cancer: timing of initiation and optimal duration
    Cruz, Jan Paolo M.
    Pales, Chris George C.
    Kim, Kwang Min
    Kim, Young Wan
    JOURNAL OF BUON, 2018, 23 (03): : 568 - 573
12345